Back to search
Platinum-resistant Recurrent Ovarian Cancer (PROC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Platinum-resistant Recurrent Ovarian Cancer (PROC) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Platinum-resistant Recurrent Ovarian Cancer (PROC) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A Phase 1, single-arm, single-center, open-label, prospective, dose-escalation, and cohort expansion study to assess the safety, tolerability, pharmacokinetic (…
As one of the gynecological malignancies with the highest incidence and mortality rates worldwide, ovarian cancer treatment faces the significant challenge of p…